[Organic hypoglycemia in association with a malignant tumor and an islet cell adenoma. Determining role of blood insulin determination for the etiologic diagnosis and surgical procedure].
D000236:Adenoma / Q000150:complications*; D007516:Adenoma, Islet Cell / Q000150:complications* / Q000473:pathology; D000368:Aged; D001120:Arginine / Q000008:administration & dosage; D002277:Carcinoma / Q000150:complications; D003981:Diazoxide / Q000008:administration & dosage; D005260:Female; D005934:Glucagon / Q000097:blood; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000175:diagnosis; D007003:Hypoglycemia / Q000150:complications* / Q000209:etiology; D007328:Insulin / Q000097:blood*; D007680:Kidney Neoplasms / Q000150:complications*; D010179:Pancreas / Q000473:pathology; D011863:Radioimmunoassay
D007328:Insulin; D005934:Glucagon; D001120:Arginine; D003981:Diazoxide
Hypoglycémie organique avec association d'une tumeur maligne rénale et d'un adénome langerhansien. Rôle déterminant des dosages d'insulinémie pour le diagnostic étiologique et la conduite chirurgicale.